Lack of efficacy of liposomal glucantime in the treatment of cutaneous leishmaniasis

Indian J Dermatol Venereol Leprol. 2016 May-Jun;82(3):347-9. doi: 10.4103/0378-6323.175918.

Authors

Vahid Mashayehki Ghoyonlo, Mahmoud Reza Jafari, Mohammad Javad Yazdanpanah, Habiballah Esmaili, Soleiman Noori, Bita Kiafar¹

Affiliation

¹ Cutaneous Leishmaniasis Research Center, Department of Dermatology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

PMID: 27088953
DOI: 10.4103/0378-6323.175918

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Topical
Adolescent
Adult
Antiprotozoal Agents / administration & dosage*
Child
Child, Preschool
Drug Compounding
Female
Humans
Leishmaniasis, Cutaneous / diagnosis*
Leishmaniasis, Cutaneous / drug therapy*
Liposomes
Male
Meglumine / administration & dosage*
Meglumine Antimoniate
Middle Aged
Organometallic Compounds / administration & dosage*
Pilot Projects
Treatment Outcome
Young Adult

Substances

Antiprotozoal Agents
Liposomes
Organometallic Compounds
Meglumine
Meglumine Antimoniate